Join Us at the 5th International Antibody Validation Meeting
5
Min Read
In this blog:
- What to expect from the 5th International Antibody Validation Meeting
- Meet our speakers
- And a big thanks to our sponsors!
The 5th International Antibody Validation Meeting this year will bring together leaders from academia, pharma, biotech, and reagent suppliers to share insights, foster discussions, and drive progress in antibody validation.
Whether you’re in research, development, or supply, this is a unique opportunity to get involved in the antibody validation conversation and help to drive progress.
What to Expect
- Insightful Talks: Hear from a range of leading scientists from academia, pharma and reagent vendors. We already have over 20 confirmed speakers, with more to be announced.
- Poster Session: There is ample time for discussion during the poster session where attendees can get even more insight from presenters.
- Discussion and Networking: We keep the meeting capped at 120 delegates to ensure there is a focused group and opportunity to meet everyone. Great discussion has been a defining feature of previous events.
- Meeting Dinner and Evening Drinks Reception: On the second evening of the conference we host a popular meeting dinner in the beautiful city centre of Bath. This is included as part of the ticket to the event. We also host an evening drinks reception on night one.
Introducing the 2025 Speakers
We are really excited by the meeting speakers we have confirmed so far. They represent a variety of disciplines in the industry, all with impressive experience, expertise and perspectives to share.
The Speakers:
- Danielle Callahan – Director, Global Product Management, Proteintech
- Elisia Clark – Associate Director, Research Programs, The Michael J. Fox Foundation for Parkinson’s Research
- Carly Dix – Associate Director Biologics Engineering, AstraZeneca
- Johan Duchêne – Senior Lecturer, Ludwig Maximilian University of Munich
- Myriam Duckely – Senior Principal Scientist, Novartis
- Björn Forsström – Senior Scientist, Olink Proteomics
- Will Howat – VP of Validation and Technical Quality, Abcam
- Elena Ivanova – Head of Preclinical Histology Core, Regeneron
- Carl Laflamme – Team Leader of the Antibody Characterisation Group, YCharOS/ Only Good Antibodies
- Ulf Landegren – Professor of Molecular Medicine, Uppsala University
- Thierry Le Bihan – Principal Scientist, Rapid Novor
- Leticia Montoya – R&D Scientist, Thermo Fisher Scientific
- Deborah Moshinsky – Director of Antibody Characterization and Validation, Institute for Protein Innovation (IPI)
- Nidhi Nath – Director Antibody Development, Bio-Techne
- Roberto Polakiewicz – CSO, Cell Signaling Technology
- Andrea Radtke – Principal Scientist, Leica Microsystems
- Jim Trimmer – Distinguished Professor Emeritus, University of California, Davis
- Michael Weiner – Founder and CTO Precision BioTools
- Libby Wiseman – Senior Scientist, AstraZeneca
Learn more about them on the Antibody Validation Meeting website.
Our Sponsors
This meeting wouldn’t be possible without the generous support of our sponsors. Their contributions of experience, data and insight on improving antibody validation is invaluable to the meeting. Thank you to:
- Abcam
- Atlas Antibodies
- Bio-Techne
- Cell Signaling Technology
- Diana Biotech
- DSHB
- GeneTex
- HuaBio
- In Vivo Biotech
- Precision BioTools
- Proteintech
- Thermo Fisher Scientific
- VectorBuilder
Many of these sponsors will be talking at the event, bringing valuable perspectives from the supplier side of the conversation, or exhibiting, offering the chance to connect with them further.
Register now
We hope you’ll join us in Bath this September! If you have any questions, please don’t hesitate to reach out to the organising team.
- Skye and the CiteAb team
